{{Drugbox
| Watchedfields = changed
| verifiedrevid = 444397365
| IUPAC_name = (''RS'')-3-[(2-Hydroxy-1-methyl-2-phenylethyl)amino]-1-(3-methoxyphenyl)propan-1-one
| image = Oxyfedrine.svg
| width = 275

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|oxyfedrine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| index_label =
| index2_label =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 15687-41-9
| ATC_prefix = C01
| ATC_suffix = DX03
| PubChem = 27454
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = DWL616XF1K
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08321
| PubChem2 = 5489013
| ChemSpiderID = 4590049

<!--Chemical data-->
| C=19 | H=23 | N=1 | O=3 
| molecular_weight = 313.39 g/mol
| smiles = C[C@@H]([C@@H](c1ccccc1)O)NCCC(=O)c2cccc(c2)OC
| StdInChI = 1S/C19H23NO3/c1-14(19(22)15-7-4-3-5-8-15)20-12-11-18(21)16-9-6-10-17(13-16)23-2/h3-10,13-14,19-20,22H,11-12H2,1-2H3/t14-,19-/m0/s1
| StdInChIKey = GDYUVHBMFVMBAF-LIRRHRJNSA-N
}}

'''Oxyfedrine''' is a [[vasodilator]] and a [[Beta-adrenergic agonist|β adrenoreceptor agonist]]. It was found to depress the tonicity of coronary vessels, improve myocardial metabolism (so that heart can sustain hypoxia better) and also exert a positive chronotropic and inotropic effects, thereby not precipitating [[angina pectoris]]. The latter property (positive chronotropic and inotropic effects) is particularly important, because other vasodilators used in angina may be counter productive causing coronary steal phenomenon. 

Synergistic effects with [[antibiotic]]s have been suggested.<ref name="pmid15802815">{{cite journal 
 | title = In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains
 | journal = Biol. Pharm. Bull.
 | volume = 28 
 | issue = 4 
 | pages = 713–7
 | date = April 2005
 | pmid = 15802815
 | doi = 10.1248/bpb.28.713
 | url = https://www.jstage.jst.go.jp/article/bpb/28/4/28_4_713/_article
 | first = Kaushiki
 | last = Mazumdar
 | first2 = Noton Kumar
 | last2 = Dutta
 | first3 = Kuppusamy Asok
 | last3 = Kumar
 | first4 = Sujata Ghosh
 | last4 = Dastidar
}}</ref>

==References==
{{reflist}}

{{Adrenergic agonists}}
{{Vasodilators used in cardiac diseases}}

[[Category:Vasodilators]]
[[Category:Phenethylamines]]
[[Category:Phenol ethers]]
[[Category:Aromatic ketones]]

{{cardiovascular-drug-stub}}